Novel Strategies for Innovating Deceased Donor Procurement



Status:Recruiting
Conditions:Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:3/17/2019
Start Date:January 2017
End Date:December 2020
Contact:Amanda M Bartosic, MBA
Email:abartosic@som.umaryland.edu
Phone:410-328-0038

Use our guide to learn which trials are right for you!

Despite many efforts to increase the size of the donor pool, there is a large and growing
disparity between the number of donor kidneys available for transplantation and the number of
patients on the transplant waiting list. Increasing the quality of currently available donor
kidneys would potentially improve the longevity of deceased donor kidney transplants by
years, thus increasing the rate of transplantation patients on the kidney transplant waiting
list. In addition, recipients of higher quality kidneys have shorter hospital stays and lower
total hospital charges. By innovating the organ donation process, such that deceased donor
kidneys are removed prior to the cessation of cardiac activity, rather than after, it may be
possible to improve the quality of the kidney before transplantation, resulting in improved
function after transplantation and increased longevity of these transplanted kidneys.
Further, this improved kidney quality is highly likely to translate to reduced need for renal
dialysis and other high-cost interventions, yielding lower total hospital charges. In this
study we will test the hypothesis that, through a cost-free technical innovation, the quality
of deceased donor kidneys could be improved significantly, saving thousands more lives per
year and reducing total health care expenditures on renal transplantation.


Inclusion Criteria:

1. Currently listed to receive a deceased donor kidney transplant

2. Able to fully understand the informed consent document

3. Recipient over the age of 18 years

Exclusion Criteria:

1. Recipients undergoing a bilateral native nephrectomy at time of transplant

2. Recipients undergoing dual (liver-kidney, kidney-pancreas, pediatric en bloc)
transplant

3. Individuals who are unable to understand the informed consent document

4. Recipient under age 18 years

5. Recipients receiving desensitization protocols for high levels of donor specific
antibodies
We found this trial at
1
site
Baltimore, Maryland 20742
(301) 405-1000
University of Maryland As a globally-connected university offering a world-class education, the University of Maryland...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials